inventory!

*Only for medical professionals to read for reference.
In 2021, what important guidelines will be updated in the field of rheumatism? Fast forward to favorites! 01 Gout 1 2020 China's "Gout Diagnosis and Treatment Standards" This year, the newly released "Guidelines for the Rational Use of Gout Primary Medicines in 2021" and the classic "Chinese Hyperuricemia and Gout Diagnosis and Treatment Guidelines (2019)" and other guidelines are still better this year.
There is controversy
.

This article makes a horizontal comparison between the "Guidelines for the Rational Use of Gout Medications at the Primary Level in 2021" for primary doctors and the "Chinese Guidelines for the Diagnosis and Treatment of Hyperuricemia and Gout (2019)" which is more inclined to specialist doctors in the diagnosis and treatment of gout, hoping to clarify The ins and outs of the controversy have inspired everyone
.

Is benzbromarone still the first-line uric acid lowering drug? The 2021 Gout Grassroots Guide has something to say! 2 "2021 Asia Pacific Rheumatism Alliance (APLAR) Gout Management Guidelines" Director Zhu Xiaoxia, Department of Rheumatology and Immunology, Huashan Hospital Affiliated to Fudan University, said that the "2021 APLAR Gout Management Guidelines" take into account clinical practice while also taking into account regional characteristics
.

It not only includes common problems in gout management, such as diet and drinking, weight management, acute anti-inflammatory treatment, choice and timing of uric acid lowering drugs, etc.
, but also includes hot issues in the treatment of asymptomatic hyperuricemia and refractory gout
.

In addition, the guide has fully evidence-based the traditional treatment methods such as acupuncture and herbal medicine in some countries in the Asia-Pacific region, and gives relevant recommendations
.

The management guide is based on the background discussion in the Asia-Pacific region.
Most of the recommendations are worthy of reference, but they are not entirely suitable for China's national conditions
.

Therefore, it is very necessary to formulate or update China's gout management guidelines based on actual conditions
.

Regarding gout, APLAR has given 18 latest recommendations! 02 Rheumatoid Arthritis (RA) 1 "American College of Rheumatology (ACR) RA Treatment Guidelines" In June 2021, the new version of "ACR RA Treatment Guidelines" was officially released
.

After six years, ACR updated the RA guidelines again
.

On the basis of the 2015 version of the guidelines, combined with the new evidence and new developments in the field of RA in recent years, it provides detailed treatment advice for rheumatologists
.

In-depth interpretation of the 2021 version of the ACR guidelines, grasp the new direction of RA treatment 2 "D2T-RA Treatment Guidance and Recommendations" Some RA patients have traditionally synthesized disease-improving anti-rheumatic drugs (csDMARDs), biological DMARDs (bDMARDs) and/or in several cycles After targeted synthesis of DMARDs (tsDMARDs) did not achieve low disease activity or remission, these patients may be referred to as patients with refractory RA (D2T-RA)
.

In order to better address the needs of patients with refractory RA, the European Union Against Rheumatism (EULAR) issued the first "Guiding Recommendations for D2T-RA Treatment" on August 18
.

RA treatment is always bad, what should I do? These EULAR suggestions are so useful! Other: How to treat rheumatoid arthritis? The 2020 JCR Clinical Practice Guide is the first to see! 03 Systemic lupus erythematosus (SLE) In view of the unique characteristics of SLE in Asian populations, APLAR lasted more than 2 years and organized experts in the Asia-Pacific region to discuss and revise several times, and finally published in 2021 SLE management guidelines that are more suitable for people in the Asia-Pacific region
.

More suitable for Asian crowd! The 2021 Lupus Management Guidelines are updated.
At the 2021 APLAR Annual Conference, Professor Mo Zhichao from Tuen Mun Hospital in Hong Kong pointed out: The APLAR SLE Management Guidelines consist of 34 statements.
Later APLAR will continue to update based on newly discovered evidence.
This section belongs to the Asia-Pacific region.
Guide
.

In this statement, there are still content worthy of in-depth discussion, including the status of belyumumab in the treatment of lupus nephritis (LN), new coronavirus vaccination, pulmonary hypertension and interstitial lung disease screening, thrombopoietin Receptor agonists for treatment of refractory immune thrombocytopenia, cardiovascular and osteoporosis risk factors and complication screening, etc.
, while problems related to pregnancy, assisted reproduction and obstetric antiphospholipid syndrome require additional expert investigation Meeting discussion
.

Others: Compare the three major guidelines for lupus erythematosus and see the Asia-Pacific Management Consensus 04 Osteoporosis.
The current clinical anti-osteoporosis drugs are mainly divided into two categories, bone formation agents and bone resorption inhibitors
.

However, the current clinical use of osteoporosis drugs is still not standardized.
In order to advance a standardized clinical use of osteoporosis drugs, the "Guidelines for the Rational Use of Osteoporosis Primary Medicines" issued in 2021 will guide doctors to better use drugs
.

How to treat osteoporosis best? 7 watch straps you understand! Others: Are people worried about osteoporosis in middle age? It's right to do this at 14 o'clock! The authoritative interpretation of the "2020 China Expert Consensus on the Prevention and Treatment of Glucocorticoid Osteoporosis" is here! Professor Zhang Xuewu 05 About 1/6 of SS patients with Sjogren’s syndrome (SS) have lung damage.
This year, ACR issued a consensus guideline on the assessment and management of SS lung disease, containing 52 practical recommendations
.

The latest consensus of ACR! Sjogren’s syndrome lung disease "diagnosis and treatment flowchart" is here 06 Osteoarthritis (OA) 1 "Chinese Osteoarthritis Diagnosis and Treatment Guidelines (2019 Edition)" In recent years, ACR, EULAR, American Academy of Orthopaedic Surgeons (AAOS), International Bone The Arthritis Research Society (OARSI), the Chinese Society of Rheumatology, and the Joint Surgery Group of the Chinese Orthopaedic Association have formulated or revised their respective OA diagnosis and treatment guidelines, which provide an important reference for the clinical diagnosis and treatment of OA
.

However, some of the guidelines have problems such as incomplete search evidence, unclear investigation of clinical problems, lack of grading of the quality of evidence and the strength of recommendations
.

In this regard, China has issued the "Guidelines for the Diagnosis and Treatment of Osteoarthritis in China (2019 Edition)" which can make up for the above shortcomings and provide Chinese clinicians with the best decision-making tools for OA diagnosis and treatment
.

This guideline addresses the 16 issues that clinicians are most concerned about, and makes recommendations based on the latest clinical evidence
.

Wonderful first look! The latest Chinese guidelines for the diagnosis and treatment of osteoarthritis are published.
2EULAR's first intra-articular treatment (IAT) recommends that the use and delivery of IAT in patients with arthritis are very different, and there has been no evidence-based recommendation in the past
.

To bridge this gap, EULAR established a working group to develop evidence-based recommendations to help guide medical professionals in the use of IAT in adult patients with peripheral joint disease
.

The recommendation establishes 5 general principles and 11 recommendations, and solves the safety issues and preventive measures that need to be resolved in special populations, repeated joints with patient information, diagnosis and treatment procedures, treatment sites, accuracy, routine and special aseptic care, and special populations.
Issues related to the effectiveness and safety of injections, the use of local anesthetics, and follow-up care
.

The first recommendations based on evidence and expert opinions were developed to guide health professionals in the use of IAT
.

EULAR: The first proposal for intra-articular treatment! Just look at these two tables! 07 Fibromyalgia (FM) FM, also known as fibromyalgia syndrome, is a chronic diffuse pain syndrome caused by central nervous system sensory afferent processing dysfunction.
Its main symptoms include multi-site pain, severe fatigue, and stiffness , Sleep disorders, cognitive disorders and psychological problems have a serious impact on the quality of life of patients
.

In this regard, the "Consensus of Chinese Experts on the Clinical Diagnosis and Treatment of Fibromyalgia" was published in the "Chinese Journal of Pain Medicine", summarizing the main points of diagnosis and treatment of FM
.

How is fibromyalgia diagnosed and treated? Look at the latest China consensus! 08 The sensitivity of the 1990 ACR classification criteria for vasculitis has declined significantly in the past 30 years
.

With the deepening of the understanding of the pathophysiology of vasculitis, and the innovation and application of related clinical diagnostic methods, the revision of the classification standard for primary vasculitis has been put on the agenda, and the new classification standard of ACR/EULAR vasculitis has attracted much attention.

.

Updated for the first time in 30 years, the ACR "Vasculitis Classification Standard" is here! 09 Rheumatism and New Coronary Vaccine In March 2021, ACR issued the "Guidelines for Vaccination against COVID-19 for Patients with Rheumatism and Musculoskeletal Disease (RMD)", general precautions, recommendations and immunomodulatory treatment for such patients The medication use and time have been sorted out, aiming to better provide vaccination advice for patients with rheumatism and promote the implementation of vaccination for RMD patients
.

ACR's latest guide: Should rheumatism patients get the new crown vaccine? You can understand the 3 watch straps! Others: Can patients with rheumatism get the new crown vaccine? Which type? my country's guidelines are coming | CRA 2021ACR's latest vaccination guidelines for patients with rheumatism are released.
What has been updated? In order to better provide you with interesting, useful, and attitude content, the Medical Rheumatism Channel welcomes everyone to move their fingers to complete the following surveys.
It only takes five seconds!